{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:22:43Z","timestamp":1760955763408},"reference-count":94,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1053\/j.jrn.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:15:43Z","timestamp":1510683343000},"page":"73-82","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Myth of Water and Salt: From Aquaretics to Tenapanor"],"prefix":"10.1053","volume":"28","author":[{"given":"Luca","family":"Visconti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Cernaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Calimeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lacquaniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Alberto","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Lacava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2017.06.005_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1113\/expphysiol.2007.038695","article-title":"Claude Bernard, the first systems biologist, and the future of physiology","volume":"93","author":"Noble","year":"2008","journal-title":"Exp Physiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib2","first-page":"777","article-title":"Marine serum, concept of its inventor, Ren\u00e9 Quinton; possibility of its application today","volume":"43","author":"Mariotti","year":"1952","journal-title":"Minerva Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.70.1821.500-a","article-title":"Pharmacological injections and physiological inferences","volume":"70","author":"Cannon","year":"1929","journal-title":"Science"},{"key":"10.1053\/j.jrn.2017.06.005_bib4","series-title":"The Hunger for Salt","author":"Denton","year":"1982"},{"key":"10.1053\/j.jrn.2017.06.005_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0079-6123(08)00443-3","article-title":"Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis","volume":"170","author":"Llorens-Cortes","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1053\/j.jrn.2017.06.005_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2400","article-title":"Central mechanisms of osmosensation and systemic osmoregulation","volume":"9","author":"Bourque","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1053\/j.jrn.2017.06.005_bib7","first-page":"209","article-title":"Influence of antidipsogenic peptides of the mammalian brain on electrolyte and water balance","volume":"4","author":"De Caro","year":"1985","journal-title":"Regul Pept Suppl"},{"key":"10.1053\/j.jrn.2017.06.005_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0196-9781(85)90372-9","article-title":"Water intake modification induced by tachykinins, bombesin and opioid peptides","volume":"6","author":"De Caro","year":"1985","journal-title":"Peptides Suppl 3"},{"key":"10.1053\/j.jrn.2017.06.005_bib9","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V76842","article-title":"Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action","volume":"7","author":"Bouby","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib10","doi-asserted-by":"crossref","first-page":"F917","DOI":"10.1152\/ajprenal.00413.2010","article-title":"Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?","volume":"299","author":"Bankir","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib11","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1681\/ASN.2006040356","article-title":"Renin-angiotensin-aldosterone system and progression of renal disease","volume":"17","author":"Ruster","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib12","first-page":"F898","article-title":"Arginine vasopressin promotes growth of rat glomerular mesangial cells in culture","volume":"255","author":"Ganz","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib13","first-page":"F973","article-title":"Effect of water intake on the progression of chronic renal failure in the 5\/6 nephrectomized rat","volume":"258","author":"Bouby","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1046\/j.1523-1755.1999.00443.x","article-title":"High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-beta","volume":"55","author":"Sugiura","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0272-6386(03)00193-8","article-title":"High urine volume and low urine osmolality are risk factors for faster progression of renal disease","volume":"41","author":"Hebert","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2017.06.005_bib16","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1681\/ASN.2005101106","article-title":"Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease","volume":"17","author":"Wang","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1440-1797.2010.01415.x","article-title":"Fluid and nutrient intake and risk of chronic kidney disease","volume":"16","author":"Strippoli","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1053\/j.jrn.2017.06.005_bib18","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.2215\/CJN.01990211","article-title":"Urine volume and change in estimated GFR in a community-based cohort study","volume":"6","author":"Clark","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000350377","article-title":"Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data","volume":"37","author":"Sontrop","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib20","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ndt\/gft507","article-title":"Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: a population-based longitudinal cohort study","volume":"29","author":"Palmer","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.06.005_bib21","doi-asserted-by":"crossref","first-page":"e93226","DOI":"10.1371\/journal.pone.0093226","article-title":"Urine osmolarity and risk of dialysis initiation in a chronic kidney disease cohort\u2013a possible titration target?","volume":"9","author":"Plischke","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.jrn.2017.06.005_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000104435","article-title":"Lithiasis and risk factors","volume":"79","author":"Ferrari","year":"2007","journal-title":"Urol Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5694\/j.1326-5377.1993.tb137913.x","article-title":"Influence of season, age, and sex on renal stone formation in South Australia","volume":"159","author":"Baker","year":"1993","journal-title":"Med J Aust"},{"key":"10.1053\/j.jrn.2017.06.005_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1464-410X.1990.tb14954.x","article-title":"Chronic dehydration stone disease","volume":"66","author":"Embon","year":"1990","journal-title":"Br J Urol"},{"key":"10.1053\/j.jrn.2017.06.005_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/occmed\/42.1.30","article-title":"Dehydration from outdoor work and urinary stones in a tropical environment","volume":"42","author":"Pin","year":"1992","journal-title":"Occup Med (lond)"},{"key":"10.1053\/j.jrn.2017.06.005_bib26","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0022-5347(17)35887-1","article-title":"Hot occupation and nephrolithiasis","volume":"150","author":"Borghi","year":"1993","journal-title":"J Urol"},{"key":"10.1053\/j.jrn.2017.06.005_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00240-003-0373-7","article-title":"Occupational risk for nephrolithiasis and bladder dysfunction in a chauffeur","volume":"32","author":"Chang","year":"2004","journal-title":"Urol Res"},{"key":"10.1053\/j.jrn.2017.06.005_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4314\/wajm.v23i2.28108","article-title":"Chronic dehydration and symptomatic upper urinary tract stones in young adults in Ibadan, Nigeria","volume":"23","author":"Olapade-Olaopa","year":"2004","journal-title":"West Afr J Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-126-7-199704010-00001","article-title":"Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women","volume":"126","author":"Curhan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib30","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1097\/01.ASN.0000146012.44570.20","article-title":"Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up","volume":"15","author":"Taylor","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archinte.164.8.885","article-title":"Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II","volume":"164","author":"Curhan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1681\/ASN.V8101568","article-title":"Family history and risk of kidney stones","volume":"8","author":"Curhan","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0002-9343(82)90566-6","article-title":"Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study","volume":"72","author":"Strauss","year":"1982","journal-title":"Am J Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0022-5347(17)51711-5","article-title":"The stone clinic effect in patients with idiopathic calcium urolithiasis","volume":"130","author":"Hosking","year":"1983","journal-title":"J Urol"},{"key":"10.1053\/j.jrn.2017.06.005_bib35","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1523-1755.2005.00292.x","article-title":"Serial crystalluria determination and the risk of recurrence in calcium stone formers","volume":"67","author":"Daudon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-5347(01)66321-3","article-title":"Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study","volume":"155","author":"Borghi","year":"1996","journal-title":"J Urol"},{"key":"10.1053\/j.jrn.2017.06.005_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"Devuyst","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.jrn.2017.06.005_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and\u00a0secretion in human polycystic kidney epithelial cells","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib39","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib40","doi-asserted-by":"crossref","first-page":"F261","DOI":"10.1152\/ajprenal.00345.2014","article-title":"Effects of hydration in rats and mice with polycystic kidney disease","volume":"308","author":"Hopp","year":"2015","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2215\/CJN.03950510","article-title":"Water prescription in autosomal dominant polycystic kidney disease: a pilot study","volume":"6","author":"Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib42","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfu093","article-title":"Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?","volume":"29","author":"Higashihara","year":"2014","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.jrn.2017.06.005_bib43","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1517\/13543784.2015.1059421","article-title":"An\u00a0overview of experimental and early investigational therapies for the treatment of polycystic kidney disease","volume":"24","author":"Santoro","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.jrn.2017.06.005_bib44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.urolonc.2008.12.014","article-title":"Aquaretic inhibits renal cancer proliferation: role of vasopressin receptor-2 (V2-R)","volume":"28","author":"Bolignano","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1053\/j.jrn.2017.06.005_bib45","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2362.2008.02024.x","article-title":"Aquaretic-induced apoptosis: a cure or a curse?","volume":"38","author":"Bolignano","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.jrn.2017.06.005_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/138161207780363040","article-title":"Aquaretic agents: what's beyond the treatment of hyponatremia?","volume":"13","author":"Bolignano","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.jrn.2017.06.005_bib47","article-title":"From hyponatremia to tolvaptan","volume":"31","author":"Cernaro","year":"2014","journal-title":"G Ital Nefrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2015.143","article-title":"Will introduction of tolvaptan change clinical practice in autosomal dominant polycystic kidney disease?","volume":"88","author":"Horie","year":"2015","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib49","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2215\/CJN.03530411","article-title":"TEMPO Formula and 156-05-002 Study Investigators. Tolvaptan in autosomal dominant polycystic\u00a0kidney disease: three years' experience","volume":"6","author":"Higashihara","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib50","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib51","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2215\/CJN.06300615","article-title":"TEMPO 3:4 Trial Investigators. Effect of tolvaptan in autosomal dominant polycystic kidney disease by CKD stage: results from the TEMPO 3:4 Trial","volume":"11","author":"Torres","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib52","unstructured":"EMA\/CHMP\/130684\/2015 Press Office. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2015\/02\/WC500183299.pdf. Accessed April 18,\u00a02016."},{"key":"10.1053\/j.jrn.2017.06.005_bib53","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMra064486","article-title":"Sodium and potassium in the pathogenesis of hypertension","volume":"356","author":"Adrogu\u00e9","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1053\/j.jrn.2017.06.005_bib54","first-page":"S61","article-title":"Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association","volume":"31","author":"Bantle","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2017.06.005_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3945\/an.111.000430","article-title":"U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, January 2011","volume":"2","author":"McGuire","year":"2011","journal-title":"Adv Nutr"},{"key":"10.1053\/j.jrn.2017.06.005_bib56","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2017.06.005_bib57","series-title":"Guideline: Sodium Intake for Adults and Children","year":"2012"},{"key":"10.1053\/j.jrn.2017.06.005_bib58","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2017.06.005_bib59","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.2337\/dc14-S120","article-title":"Nutrition therapy recommendations for the management of adults with diabetes","volume":"37","author":"Evert","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1053\/j.jrn.2017.06.005_bib60","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","volume":"63","author":"Eckel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib61","series-title":"Australian Dietary Guidelines","year":"2013"},{"key":"10.1053\/j.jrn.2017.06.005_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J Hypertens"},{"key":"10.1053\/j.jrn.2017.06.005_bib63","series-title":"U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015 \u2013 2020 Dietary Guidelines for Americans","year":"2015"},{"key":"10.1053\/j.jrn.2017.06.005_bib64","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm1095-1009","article-title":"The effect of increased salt intake on blood pressure of chimpanzees","volume":"1","author":"Denton","year":"1995","journal-title":"Nat Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib65","first-page":"626S","article-title":"The INTERSALT Study: background, methods, findings, and implications","volume":"65","author":"Stamler","year":"1997","journal-title":"Am J Clinnutr"},{"key":"10.1053\/j.jrn.2017.06.005_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1056\/NEJM200101043440101","article-title":"Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet.\u00a0DASH-Sodium Collaborative Research Group","volume":"344","author":"Sacks","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.2013.14","article-title":"Rapid dephosphorylation of the renal sodium chloride cotransporter in response to oral potassium intake in mice","volume":"83","author":"Sorensen","year":"2013","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib68","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/CIRCULATIONAHA.105.555474","article-title":"Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population","volume":"112","author":"Tobin","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2017.06.005_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3945\/an.113.005033","article-title":"Institute of Medicine. 2013. \u201cSodium intake in populations: assessment of evidence.\u201d Washington, DC: The National Academies Press, 2013","volume":"5","author":"McGuire","year":"2014","journal-title":"Adv Nutr"},{"key":"10.1053\/j.jrn.2017.06.005_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamainternmed.2014.6278","article-title":"Dietary sodium content, mortality, and risk for cardiovascular events in older adults: the Health, Aging, and Body Composition (Health ABC) Study","volume":"175","author":"Kalogeropoulos","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ajh.2011.115","article-title":"Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review)","volume":"24","author":"Taylor","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1053\/j.jrn.2017.06.005_bib72","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMsb1607161","article-title":"Dietary sodium and cardiovascular disease risk\u2013measurement matters","volume":"375","author":"Cogswell","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00125-003-1303-5","article-title":"Effect of sodium intake on blood pressure and albuminuria in type 2 diabetic patients: the role of insulin resistance","volume":"47","author":"Vedovato","year":"2004","journal-title":"Diabetologia"},{"key":"10.1053\/j.jrn.2017.06.005_bib74","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2796.2004.01390.x","article-title":"PREVEND Study Group. Sodium intake affects urinary albumin excretion especially in overweight subjects","volume":"256","author":"Verhave","year":"2004","journal-title":"J Intern Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib75","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.HYP.0000066844.63035.3A","article-title":"Altered renal handling of sodium in human hypertension: short review of the evidence","volume":"41","author":"Strazzullo","year":"2003","journal-title":"Hypertension"},{"key":"10.1053\/j.jrn.2017.06.005_bib76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/j.jrn.2013.11.007","article-title":"Adherence to hemodialysis dietary sodium recommendations: influence of patient characteristics, self-efficacy, and perceived barriers","volume":"24","author":"Clark-Cutaia","year":"2014","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2017.06.005_bib77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0193945905282323","article-title":"Benefits of and barriers to dietary sodium adherence","volume":"28","author":"Welch","year":"2006","journal-title":"West J Nurs Res"},{"key":"10.1053\/j.jrn.2017.06.005_bib78","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/ije\/dyp139","article-title":"Salt intakes around the world: implications for public health","volume":"38","author":"Brown","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.jrn.2017.06.005_bib79","first-page":"49","article-title":"The importance of intake: a gut feeling","volume":"3","author":"Gerritsen","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s004240050704","article-title":"S3226, a novel inhibitor of Na+\/H+ exchanger subtype 3 in various cell types","volume":"436","author":"Schwark","year":"1998","journal-title":"Pflugers Arch"},{"key":"10.1053\/j.jrn.2017.06.005_bib81","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1046\/j.1523-1755.2001.00058.x","article-title":"S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats","volume":"60","author":"Hropot","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2017.06.005_bib82","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/HYPERTENSIONAHA.112.201590","article-title":"Antihypertensive and laxative effects by pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut","volume":"60","author":"Linz","year":"2012","journal-title":"Hypertension"},{"key":"10.1053\/j.jrn.2017.06.005_bib83","doi-asserted-by":"crossref","first-page":"227ra36","DOI":"10.1126\/scitranslmed.3007790","article-title":"Intestinal inhibition of the Na+\/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans","volume":"6","author":"Spencer","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.jrn.2017.06.005_bib84","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MNH.0000000000000154","article-title":"Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management","volume":"24","author":"Spencer","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.jrn.2017.06.005_bib85","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1681\/ASN.2014030317","article-title":"Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD","volume":"26","author":"Labont\u00e9","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib86","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1517\/13543784.2014.962652","article-title":"The future of phosphate binders: a perspective on novel therapeutics","volume":"23","author":"Cernaro","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1053\/j.jrn.2017.06.005_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S78040","article-title":"Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide","volume":"9","author":"Cernaro","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1053\/j.jrn.2017.06.005_bib88","article-title":"A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers","author":"Johansson","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib89","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2215\/CJN.09050815","article-title":"Effect of tenapanor on interdialytic weight gain in patients on hemodialysis","volume":"11","author":"Block","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib90","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ajg.2017.41","article-title":"Tenapanor treatment of patients with constipation-predominant irritable bowel syndrome: a phase 2, randomized, placebo-controlled efficacy and safety trial","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.jrn.2017.06.005_bib91","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of tenapanor on serum phosphate in patients receiving hemodialysis","volume":"28","author":"Block","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.06.005_bib92","series-title":"H2O: A Biography of Water","author":"Ball","year":"1999"},{"key":"10.1053\/j.jrn.2017.06.005_bib93","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1159\/000358704","article-title":"From water to aquaretics: a legendary route","volume":"33","author":"Donato","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"10.1053\/j.jrn.2017.06.005_bib94","first-page":"1047","article-title":"Audit of the treatment of arterial hypertension in specialized consultation","volume":"92","author":"Tache","year":"1999","journal-title":"Arch Mal Coeur Vaiss"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227617301474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227617301474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T08:50:40Z","timestamp":1659862240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227617301474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1051227617301474"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2017.06.005","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Myth of Water and Salt: From Aquaretics to Tenapanor","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}